120 related articles for article (PubMed ID: 31696840)
21. Magnesium deficiency potentiates free radical production associated with myocardial infarction.
Kharb S; Singh V
J Assoc Physicians India; 2000 May; 48(5):484-5. PubMed ID: 11273138
[TBL] [Abstract][Full Text] [Related]
22. Association of oxidative stress and inflammatory markers with chronic stress in patients with newly diagnosed type 2 diabetes.
Siddiqui A; Desai NG; Sharma SB; Aslam M; Sinha UK; Madhu SV
Diabetes Metab Res Rev; 2019 Jul; 35(5):e3147. PubMed ID: 30801898
[TBL] [Abstract][Full Text] [Related]
23. The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.
Dursun B; Dursun E; Suleymanlar G; Ozben B; Capraz I; Apaydin A; Ozben T
J Diabetes Complications; 2009; 23(4):257-64. PubMed ID: 18413174
[TBL] [Abstract][Full Text] [Related]
24. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
[TBL] [Abstract][Full Text] [Related]
26. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
[TBL] [Abstract][Full Text] [Related]
27. Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy.
Sayın R; Aslan M; Kucukoglu ME; Luleci A; Atmaca M; Esen R; Demir H
Endocrine; 2014 Sep; 47(1):146-51. PubMed ID: 24347244
[TBL] [Abstract][Full Text] [Related]
28. Plasma malondialdehyde (MDA) and anti-oxidant status in diabetic retinopathy.
Kumawat M; Kharb S; Singh V; Singh N; Singh SK; Nada M
J Indian Med Assoc; 2014 Jan; 112(1):29-32. PubMed ID: 25935946
[TBL] [Abstract][Full Text] [Related]
29. Magnesium, zinc, and chromium levels in children, adolescents, and young adults with type 1 diabetes.
Lin CC; Tsweng GJ; Lee CF; Chen BH; Huang YL
Clin Nutr; 2016 Aug; 35(4):880-4. PubMed ID: 26096861
[TBL] [Abstract][Full Text] [Related]
30. Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation.
Luo ZF; Feng B; Mu J; Qi W; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):49-57. PubMed ID: 20399799
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy.
Bhatia S; Shukla R; Venkata Madhu S; Kaur Gambhir J; Madhava Prabhu K
Clin Biochem; 2003 Oct; 36(7):557-62. PubMed ID: 14563450
[TBL] [Abstract][Full Text] [Related]
33. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
[TBL] [Abstract][Full Text] [Related]
34. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
[TBL] [Abstract][Full Text] [Related]
35. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
36. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
37. Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Fujita H; Sakamoto T; Komatsu K; Fujishima H; Morii T; Narita T; Takahashi T; Yamada Y
Hypertens Res; 2011 Dec; 34(12):1302-8. PubMed ID: 21814206
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: A Randomized Controlled Clinical Trial.
Miraghajani M; Zaghian N; Mirlohi M; Feizi A; Ghiasvand R
J Ren Nutr; 2017 Sep; 27(5):317-324. PubMed ID: 28579313
[TBL] [Abstract][Full Text] [Related]
39. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
[TBL] [Abstract][Full Text] [Related]
40. Association of Serum Magnesium with Oxidative Stress in the Pathogenesis of Diabetic Cataract.
Kaliaperumal R; Venkatachalam R; Nagarajan P; Sabapathy SK
Biol Trace Elem Res; 2021 Aug; 199(8):2869-2873. PubMed ID: 33037494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
